BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1331707)

  • 1. Binding of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine to intact platelets and platelet membranes.
    Valone FH
    Methods Enzymol; 1992; 215():224-8. PubMed ID: 1331707
    [No Abstract]   [Full Text] [Related]  

  • 2. Ginkgolides and platelet-activating factor binding sites.
    Hosford DJ; Domingo MT; Chabrier PE; Braquet P
    Methods Enzymol; 1990; 187():433-46. PubMed ID: 2172741
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets.
    Homma H; Tokumura A; Hanahan DJ
    J Biol Chem; 1987 Aug; 262(22):10582-7. PubMed ID: 3038889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
    Hwang SB; Lee CS; Cheah MJ; Shen TY
    Biochemistry; 1983 Sep; 22(20):4756-63. PubMed ID: 6313047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes.
    Chau LY; Tsai YM; Cheng JR
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1070-6. PubMed ID: 2545193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development of platelet-activating factor antagonists.
    Shen TY; Hussaini I; Hwang SB; Chang MN
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():359-62. PubMed ID: 2546389
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets.
    Nishihira J; Ishibashi T; Imai Y; Muramatsu T
    Tohoku J Exp Med; 1985 Oct; 147(2):145-52. PubMed ID: 3001971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and metabolism of platelet-activating factor by human neutrophils.
    O'Flaherty JT; Surles JR; Redman J; Jacobson D; Piantadosi C; Wykle RL
    J Clin Invest; 1986 Aug; 78(2):381-8. PubMed ID: 3016027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of platelet activating factor by isolated membranes from U937 cells.
    Lee JS; Ong R; Yoo TJ; Chiang T
    Cell Immunol; 1990 Feb; 125(2):415-25. PubMed ID: 2153465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
    Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor binding to human platelet membranes.
    Valone FH; Ruis NM
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of platelet activating factor to albumin.
    Clay KL; Johnson C; Henson P
    Biochim Biophys Acta; 1990 Oct; 1046(3):309-14. PubMed ID: 2171672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine.
    Valone FH
    Immunology; 1984 May; 52(1):169-74. PubMed ID: 6325330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients.
    Hershkowitz M; Adunsky A
    Neurobiol Aging; 1996; 17(6):865-8. PubMed ID: 9363797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets.
    Kloprogge E; Mommersteeg M; Akkerman JW
    J Biol Chem; 1986 Aug; 261(24):11071-6. PubMed ID: 3015954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition of tritium-labeled platelet-activating factor binding to rabbit platelet membranes by amiloride and amiloride analogs.
    Hwang SB
    Biochem Biophys Res Commun; 1989 Aug; 163(1):165-71. PubMed ID: 2549986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.
    Kudolo GB; Harper MJ
    Biol Reprod; 1989 Oct; 41(4):587-603. PubMed ID: 2559778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.